Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TNFAIP6 |
| Upstream (Parents) |
|---|
| (<<) COL15A1 → TNFAIP6 |
| (<<) SULF1 → TNFAIP6 |
| (<<) COL1A2 → TNFAIP6 |
| Downstream (Children) |
|---|
| TNFAIP6 → EGR2 (>>) |
| TNFAIP6 → DGCR14 (>>) |
| TNFAIP6 → SERPINE2 (>>) |
| TNFAIP6 → ESM1 (>>) |
| TNFAIP6 → RASL12 (>>) |
| TNFAIP6 → GJC1 (>>) |
| TNFAIP6 → CHST1 (>>) |
| TNFAIP6 → CD200 (>>) |
| TNFAIP6 → HMX1 (>>) |
| TNFAIP6 → EMP1 (>>) |
| TNFAIP6 → PLAU (>>) |
| TNFAIP6 → C1orf46 (>>) |
| TNFAIP6 → DGKI (>>) |
| TNFAIP6 → HSPA1L (>>) |
| TNFAIP6 → POLRMT (>>) |
| TNFAIP6 → SCG2 (>>) |
| TNFAIP6 → WISP1 (>>) |
| TNFAIP6 → GULP1 (>>) |
| TNFAIP6 → TMEM158 (>>) |
| TNFAIP6 → PRR16 (>>) |
